Pfizer sees 10% operational growth with Covid vaccine

CNBC Television published this video item, entitled “Pfizer sees 10% operational growth with Covid vaccine” – below is their description.

Meg Tirrell joins The Exchange to discuss Pfizer’s most recent earnings report and their proposed antiviral Covid pill. They hope to have preliminary results from trials by the end of the year. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi

Pfizer said Wednesday it sold $7.8 billion in Covid-19 shots in the second quarter and raised its 2021 sales forecast for the vaccine to $33.5 billion from $26 billion, as the delta variant spreads and scientists debate whether people will need booster shots.

The company’s second-quarter financial results also beat Wall Street expectations on earnings and revenue. Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

Adjusted earnings per share: $1.07 per share vs. 97 cents per share expected

Revenue: $18.98 billion vs. $18.74 billion forecast

Pfizer expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.

The company now expects full-year earnings in the range of $3.95 to $4.05 per share. That’s up from its prior range of $3.55 to $3.65 per share. It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion.

Shares of Pfizer rose 2.5% in intraday trading.

“The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement. “Most visibly, the speed and efficiency of our efforts with BioNTech to help vaccinate the world against COVID-19 have been unprecedented, with now more than a billion doses of BNT162b2 having been delivered globally.”

Pfizer’s other business units also saw strong sales growth. Revenue from its oncology unit rose by 19% year over year to $3.1 billion. The company’s hospital unit generated $2.2 billion in revenue, up 21% from the prior year. Its internal medicine unit grew by 5% from a year ago to $2.4 billion.

Pfizer said earlier this month it was seeing signs of waning immunity induced by its Covid vaccine with German drugmaker BioNTech, and planned to ask the Food and Drug Administration to authorize a booster dose. It also said it is developing a booster shot to target the delta variant.

The Centers for Disease Control and Prevention and the World Health Organization don’t recommend Covid booster shots at this time.

Dr. Kate O’Brien, WHO’s director of immunization, vaccines and biologicals, said Wednesday the organization is still researching whether a booster shot is needed to increase protection.

“We’re very clear on this, there’s not enough information to provide a recommendation at this point,” O’Brien said in a Q&A interview posted on the organization’s social media accounts. “Again, this is a very hot topic, and there’s a lot of research going on to be able to provide an evidence-based recommendation.”

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision

» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC

» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast

Connect with CNBC News Online

Get the latest news: http://www.cnbc.com/

Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC

Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC

Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC

Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC

#CNBCTV

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Former FDIC Chair Sheila Bair is teaching children about money
  • 13,000 Haitian migrants cross into Texas
  • Security very tight around U.S. Capitol ahead of far-right rally
  • In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • FDA Panel Rejects Pfizer Booster Plan, Mulls Narrower One
  • FDA Advisers Vote Against Pfizer-BioNTech Booster Shot
  • Pope Francis Confused by Covid Vaccine Hesitancy: ‘It’s Kind of Weird’
  • Covid booster vaccines: Over 50s, care home residents and health workers to get third jab | ITV News
  • Booster Covid vaccines to be offered to over 50s to smooth ‘bumpy’ winter
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • IN FULL: ACT records seven new locally acquired cases of COVID-19 | ABC News
  • IN FULL: Victorian records 567 new cases of COVID-19 | ABC News
  • NSW records a dip in COVID cases, but 4 new deaths | 7NEWS
  • NSW records 935 new cases, Modelling predicts Victoria’s cases could soar | 9 News Australia
  • IN FULL: NSW records 935 COVID-19 cases, four deaths | ABC News
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Should Queensland get drive-through vaccine clinics? | 7NEWS
  • Nightly News Full Broadcast (September 18th)
  • Queensland’s Super Pfizer Weekend continues | 7NEWS
  • Queenslanders take their shot at full vaccination amid new vaccine blitz | 7NEWS
  • Vaccine rollout for kids explained, Update to national reopening plan | 9 News Australia
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.